Table 1.
Evaluation of the response rate to PROMs depending on subgroup and neurosurgical procedure.
| In Total | Subgroups | ||||
|---|---|---|---|---|---|
| ALL | AMSB | CPA | NVC | ||
| Total no. of Patients with Completed T1 (n) | 158 | 69 | 68 | 21 | |
|
no. of patients with completed T1 per procedure (n, % in relation to no. of T1 of the corresponding group) |
surgery between T1 and T2 | 39 (24.7%) | 16 (23.2%) | 18 (26.5%) | 5 (23.8%) |
| wait-and-scan strategy | 59 (37.3%) | 24 (34.8%) | 24 (35.3%) | 11 (52.4%) | |
| previous surgery before T1 § | 60 (38.0%) | 29 (42.0%) | 26 (38.2%) | 5 (23.8%) | |
| total no. of patients with completed T2 (n) | 83 | 36 | 41 & | 6 && | |
|
no. of patients with completed T2 per procedure (n, % in relation to no. of T2 of the corresponding group) |
surgery between T1 and T2 | 25 (30.1%) | 10 (27.8%) | 13 (31.7%) | 2 (33.3%) |
| wait-and-scan strategy | 31 (37.4%) | 11 (30.5%) | 16 (39.0%) | 4 (66.7%) | |
| previous surgery before T1 | 27 (32.5%) | 15 (41.7%) | 12 (29.3%) | 0 (0.0%) | |
| total no. of patients with completed T3 (n) | 61 | 27 # | 26 ## | 8 ### | |
|
no. of patients with completed T3 per procedure (n, % in relation to no. of T3 of the corresponding group) |
surgery between T1 and T2 | 21 (34.4%) | 9 (33.3%) | 9 (34.6%) | 3 (37.5%) |
| wait-and-scan strategy | 17 (27.9%) | 7 (25.9%) | 6 (23.1%) | 4 (50.0%) | |
| previous surgery before T1 | 23 (37.7%) | 11 (40.8%) | 11 (42.3%) | 1 (12.5%) | |
ALL = total group; AMSB = subgroup “anterior and middle skull base”; CPA = subgroup “cerebellopontine angle”; NVC = subgroup “neurovascular conflict”; no. = number; n = number of completed questionnaires; T1 = initial assessment; T2 = follow-up assessment after 3 months; T3 = follow-up assessment after 12 months; “surgery between T1 and T2” = surgical treatment was performed after the initial assessment and before the follow-up assessment after 3 months; “previous surgery before T1” = surgical treatment had already been performed before the initial assessment; § = in 10/29 (34.5%) patients in subgroup AMSB and in 9/26 (34.6%) patients in subgroup CPA, surgery had been performed within 3 to 5 months before T1; &–&& = in 1 patient in subgroup CPA (&) and in 2 patients in subgroup NVC (&&), the time for T2 was not reached within the analysis period; #–### = in 9 patients in subgroup AMSB (#), in 15 patients in subgroup CPA (##), and in 3 patients in subgroup NVC (###), the time for T3 was not reached within the analysis period.